BlackRock’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.7M | Sell |
13,303,775
-285,403
| -2% | -$659K | ﹤0.01% | 2734 |
|
|
2025
Q1 | $18.9M | Buy |
13,589,178
+57,711
| +0.4% | +$80.2K | ﹤0.01% | 2943 |
|
|
2024
Q4 | $23.4M | Buy |
13,531,467
+10,934
| +0.1% | +$18.9K | ﹤0.01% | 2902 |
|
|
2024
Q3 | $27.2M | Buy |
13,520,533
+1,778,084
| +15% | +$3.57M | ﹤0.01% | 2797 |
|
|
2024
Q2 | $26.3M | Buy |
11,742,449
+9,145,146
| +352% | +$20.5M | ﹤0.01% | 2770 |
|
|
2024
Q1 | $7.45M | Sell |
2,597,303
-101,935
| -4% | -$293K | ﹤0.01% | 3449 |
|
|
2023
Q4 | $4.78M | Buy |
2,699,238
+1,951,170
| +261% | +$3.45M | ﹤0.01% | 3638 |
|
|
2023
Q3 | $2.36M | Buy |
748,068
+427,043
| +133% | +$1.35M | ﹤0.01% | 3869 |
|
|
2023
Q2 | $212K | Sell |
321,025
-76,460
| -19% | -$50.5K | ﹤0.01% | 4633 |
|
|
2023
Q1 | $317K | Sell |
397,485
-316,572
| -44% | -$252K | ﹤0.01% | 4576 |
|
|
2022
Q4 | $1.61M | Sell |
714,057
-321,592
| -31% | -$727K | ﹤0.01% | 4144 |
|
|
2022
Q3 | $2M | Sell |
1,035,649
-10,841
| -1% | -$20.9K | ﹤0.01% | 4114 |
|
|
2022
Q2 | $3.89M | Sell |
1,046,490
-1,147,213
| -52% | -$4.27M | ﹤0.01% | 3857 |
|
|
2022
Q1 | $14.3M | Sell |
2,193,703
-839,260
| -28% | -$5.47M | ﹤0.01% | 3307 |
|
|
2021
Q4 | $35.3M | Buy |
3,032,963
+10,994
| +0.4% | +$128K | ﹤0.01% | 2865 |
|
|
2021
Q3 | $56.3M | Buy |
3,021,969
+55,198
| +2% | +$1.03M | ﹤0.01% | 2559 |
|
|
2021
Q2 | $62.9M | Buy |
2,966,771
+705,526
| +31% | +$15M | ﹤0.01% | 2516 |
|
|
2021
Q1 | $45.9M | Buy |
2,261,245
+31,429
| +1% | +$638K | ﹤0.01% | 2635 |
|
|
2020
Q4 | $59.2M | Buy |
2,229,816
+389,249
| +21% | +$10.3M | ﹤0.01% | 2332 |
|
|
2020
Q3 | $41.2M | Buy |
+1,840,567
| New | +$41.2M | ﹤0.01% | 2358 |
|